The agreement with Pfizer is part of the Trump administration's strategy to implement the 'most favored nation' model, ensuring that the U.S. pays competitive prices for medications. Pfizer will reduce prices on a large scale and will launch the 'TrumpRx' platform for direct sales to patients. Additionally, the company will invest 70 billion dollars in research and production in the U.S.
Sources
Latest News
20:04
Lithuania will reintroduce general military conscription in 2032 amid tensions with Russia
20:04
The Ukrainian Navy announces that it destroyed two Su-34 aircraft at Russia’s Marinovka airfield, using Neptune missiles
19:50
Christine Lagarde explains her resignation from the ECB before the end of her term: “I want to have the freedom to speak”
19:49
Nuclearelectrica is keeping Cernavodă Units 1 and 2 in a safe shutdown state amid low Danube water levels
19:32
EU generated 1,697 kg of waste per capita in 2024, excluding major mineral waste
See more news